Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies

Major depressive disorder (MDD) is a complex disorder and a leading cause of disability in 280 million people worldwide. Many environmental factors, such as microbes, drugs, and diet, are involved in the pathogenesis of depressive disorders. However, the underlying mechanisms of depression are compl...

Full description

Bibliographic Details
Main Authors: Shabnam Nohesara, Hamid Mostafavi Abdolmaleky, Jin-Rong Zhou, Sam Thiagalingam
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/14/12/2217
_version_ 1797380880996499456
author Shabnam Nohesara
Hamid Mostafavi Abdolmaleky
Jin-Rong Zhou
Sam Thiagalingam
author_facet Shabnam Nohesara
Hamid Mostafavi Abdolmaleky
Jin-Rong Zhou
Sam Thiagalingam
author_sort Shabnam Nohesara
collection DOAJ
description Major depressive disorder (MDD) is a complex disorder and a leading cause of disability in 280 million people worldwide. Many environmental factors, such as microbes, drugs, and diet, are involved in the pathogenesis of depressive disorders. However, the underlying mechanisms of depression are complex and include the interaction of genetics with epigenetics and the host immune system. Modifications of the gut microbiome and its metabolites influence stress-related responses and social behavior in patients with depressive disorders by modulating the maturation of immune cells and neurogenesis in the brain mediated by epigenetic modifications. Here, we discuss the potential roles of a leaky gut in the development of depressive disorders via changes in gut microbiota-derived metabolites with epigenetic effects. Next, we will deliberate how altering the gut microbiome composition contributes to the development of depressive disorders via epigenetic alterations. In particular, we focus on how microbiota-derived metabolites such as butyrate as an epigenetic modifier, probiotics, maternal diet, polyphenols, drugs (e.g., antipsychotics, antidepressants, and antibiotics), and fecal microbiota transplantation could positively alleviate depressive-like behaviors by modulating the epigenetic landscape. Finally, we will discuss challenges associated with recent therapeutic approaches for depressive disorders via microbiome-related epigenetic shifts, as well as opportunities to tackle such problems.
first_indexed 2024-03-08T20:43:24Z
format Article
id doaj.art-08a28fa7e5d74fd7812b3d03f4bf8ddd
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-08T20:43:24Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-08a28fa7e5d74fd7812b3d03f4bf8ddd2023-12-22T14:11:22ZengMDPI AGGenes2073-44252023-12-011412221710.3390/genes14122217Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic TherapiesShabnam Nohesara0Hamid Mostafavi Abdolmaleky1Jin-Rong Zhou2Sam Thiagalingam3Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USANutrition/Metabolism Laboratory, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boson, MA 02215, USANutrition/Metabolism Laboratory, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boson, MA 02215, USADepartment of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USAMajor depressive disorder (MDD) is a complex disorder and a leading cause of disability in 280 million people worldwide. Many environmental factors, such as microbes, drugs, and diet, are involved in the pathogenesis of depressive disorders. However, the underlying mechanisms of depression are complex and include the interaction of genetics with epigenetics and the host immune system. Modifications of the gut microbiome and its metabolites influence stress-related responses and social behavior in patients with depressive disorders by modulating the maturation of immune cells and neurogenesis in the brain mediated by epigenetic modifications. Here, we discuss the potential roles of a leaky gut in the development of depressive disorders via changes in gut microbiota-derived metabolites with epigenetic effects. Next, we will deliberate how altering the gut microbiome composition contributes to the development of depressive disorders via epigenetic alterations. In particular, we focus on how microbiota-derived metabolites such as butyrate as an epigenetic modifier, probiotics, maternal diet, polyphenols, drugs (e.g., antipsychotics, antidepressants, and antibiotics), and fecal microbiota transplantation could positively alleviate depressive-like behaviors by modulating the epigenetic landscape. Finally, we will discuss challenges associated with recent therapeutic approaches for depressive disorders via microbiome-related epigenetic shifts, as well as opportunities to tackle such problems.https://www.mdpi.com/2073-4425/14/12/2217major depressive disordergut microbiomedietprobioticsepigenetic modifiers
spellingShingle Shabnam Nohesara
Hamid Mostafavi Abdolmaleky
Jin-Rong Zhou
Sam Thiagalingam
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
Genes
major depressive disorder
gut microbiome
diet
probiotics
epigenetic modifiers
title Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
title_full Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
title_fullStr Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
title_full_unstemmed Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
title_short Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
title_sort microbiota induced epigenetic alterations in depressive disorders are targets for nutritional and probiotic therapies
topic major depressive disorder
gut microbiome
diet
probiotics
epigenetic modifiers
url https://www.mdpi.com/2073-4425/14/12/2217
work_keys_str_mv AT shabnamnohesara microbiotainducedepigeneticalterationsindepressivedisordersaretargetsfornutritionalandprobiotictherapies
AT hamidmostafaviabdolmaleky microbiotainducedepigeneticalterationsindepressivedisordersaretargetsfornutritionalandprobiotictherapies
AT jinrongzhou microbiotainducedepigeneticalterationsindepressivedisordersaretargetsfornutritionalandprobiotictherapies
AT samthiagalingam microbiotainducedepigeneticalterationsindepressivedisordersaretargetsfornutritionalandprobiotictherapies